{"pmid":32420925,"title":"Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the \"high clinical risk\" category?","text":["Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the \"high clinical risk\" category?","We're all flying blind regarding coronavirus, but it's fair to think if thalassemic patients are particularly vulnerable to SARS-COV-2 infection or are at potential higher risk of complications from COVID-19 than normal population, specially when they become older. The frustrating thing is that, right now, this virus is still new. It only came to the attention of the World Health Organization at the end of December. Very few cases in thalassemia have so far been reported; is this due to lack of testing or a true lack of infection/susceptibility? However, we believe that more data should be collected to better characterise the impact of SARS-CoV-2 infection in patients with thalassemias. Therefore, a multicenter registry and the collection of comprehensive data from both positive COVID-19 thalassemia major and non-transfusion dependent thalassemia are necessary to clarify debated issues. In the meantime an early and vigilant monitoring along with high quality supportive care are needed in thalassemic patients at high risk for SARS-CoV-2 infection.","Acta Biomed","Karimi, Mehran","De Sanctis, Vincenzo","32420925"],"abstract":["We're all flying blind regarding coronavirus, but it's fair to think if thalassemic patients are particularly vulnerable to SARS-COV-2 infection or are at potential higher risk of complications from COVID-19 than normal population, specially when they become older. The frustrating thing is that, right now, this virus is still new. It only came to the attention of the World Health Organization at the end of December. Very few cases in thalassemia have so far been reported; is this due to lack of testing or a true lack of infection/susceptibility? However, we believe that more data should be collected to better characterise the impact of SARS-CoV-2 infection in patients with thalassemias. Therefore, a multicenter registry and the collection of comprehensive data from both positive COVID-19 thalassemia major and non-transfusion dependent thalassemia are necessary to clarify debated issues. In the meantime an early and vigilant monitoring along with high quality supportive care are needed in thalassemic patients at high risk for SARS-CoV-2 infection."],"journal":"Acta Biomed","authors":["Karimi, Mehran","De Sanctis, Vincenzo"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420925","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.23750/abm.v91i2.9592","topics":["Prevention"],"weight":1,"_version_":1667254896659791872,"score":9.490897,"similar":[{"pmid":32447232,"title":"COVID-19: beta-thalassemia subjects immunised?","text":["COVID-19: beta-thalassemia subjects immunised?","The novel coronavirus pneumonia (COVID-19) is a contagious acute respiratory infectious disease whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent PRE-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia results of a default in the hemoglobin beta-chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research.","Med Hypotheses","Lansiaux, Edouard","Pebay, Philippe Pierre","Picard, Jean-Laurent","Son-Forget, Joachim","32447232"],"abstract":["The novel coronavirus pneumonia (COVID-19) is a contagious acute respiratory infectious disease whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent PRE-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia results of a default in the hemoglobin beta-chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research."],"journal":"Med Hypotheses","authors":["Lansiaux, Edouard","Pebay, Philippe Pierre","Picard, Jean-Laurent","Son-Forget, Joachim"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447232","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.mehy.2020.109827","keywords":["beta thalassemia","correlation","favipiravir","heme","immunization","italy","novel coronavirus","regression","respiratory distress","sardinia","statistics"],"locations":["Italian","Sardinia","Sicilia"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667698385854922754,"score":358.24966},{"pmid":32440887,"title":"The EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) initiative: background and protocol for the international SARS-CoV-2 infections registry.","text":["The EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) initiative: background and protocol for the international SARS-CoV-2 infections registry.","The outbreak of SARS-CoV-2 is the worst healthcare emergency of this century, and its impact on pediatrics and neonatology is still largely unknown. The European Society for Pediatric and Neonatal Intensive Care (ESPNIC) launched the EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) international, multicenter, and multidisciplinary initiative to study the epidemiology, clinical course, and outcomes of pediatric and neonatal SARS-CoV-2 infections. EPICENTRE background and aims are presented together with protocol details. EPICENTRE is open to centers all over the world, and this will allow to provide a pragmatic picture of the epidemic, with a particular attention to pediatric and neonatal critical care issues.Conclusions: EPICENTRE will allow researchers to clarify the epidemiology, clinical presentation, and outcomes of pediatric and neonatal SARS-CoV-2 infection, refining its clinical management and hopefully providing new insights for clinicians.What is Known:* COVID19 is the new disease caused by SARS-CoV-2 infection and is spreading around the globe.* Majority of data available about SARS-CoV-2 infections originates from adult patients.What is New:* EPICENTRE is the first international, multicenter, multidisciplinary, meta-data driven, hospital-based, online, prospective cohort registry dedicated to neonatal and pediatric SARS-CoV-2 infections.* EPICENTRE will allow to understand epidemiology and physiopathology of COVID19.","Eur J Pediatr","De Luca, Daniele","Rava, Lucilla","Nadel, Simon","Tissieres, Pierre","Gawronski, Orsola","Perkins, Elisabeth","Chidini, Giovanna","Tingay, David G","32440887"],"abstract":["The outbreak of SARS-CoV-2 is the worst healthcare emergency of this century, and its impact on pediatrics and neonatology is still largely unknown. The European Society for Pediatric and Neonatal Intensive Care (ESPNIC) launched the EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) international, multicenter, and multidisciplinary initiative to study the epidemiology, clinical course, and outcomes of pediatric and neonatal SARS-CoV-2 infections. EPICENTRE background and aims are presented together with protocol details. EPICENTRE is open to centers all over the world, and this will allow to provide a pragmatic picture of the epidemic, with a particular attention to pediatric and neonatal critical care issues.Conclusions: EPICENTRE will allow researchers to clarify the epidemiology, clinical presentation, and outcomes of pediatric and neonatal SARS-CoV-2 infection, refining its clinical management and hopefully providing new insights for clinicians.What is Known:* COVID19 is the new disease caused by SARS-CoV-2 infection and is spreading around the globe.* Majority of data available about SARS-CoV-2 infections originates from adult patients.What is New:* EPICENTRE is the first international, multicenter, multidisciplinary, meta-data driven, hospital-based, online, prospective cohort registry dedicated to neonatal and pediatric SARS-CoV-2 infections.* EPICENTRE will allow to understand epidemiology and physiopathology of COVID19."],"journal":"Eur J Pediatr","authors":["De Luca, Daniele","Rava, Lucilla","Nadel, Simon","Tissieres, Pierre","Gawronski, Orsola","Perkins, Elisabeth","Chidini, Giovanna","Tingay, David G"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32440887","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s00431-020-03690-9","keywords":["children","coronavirus","database","neonate","outbreak","pandemic"],"weight":0,"_version_":1667535119494152193,"score":121.0146},{"pmid":32294811,"title":"[The keypoints in treatment of the critical coronavirus disease 2019 patient(2)].","text":["[The keypoints in treatment of the critical coronavirus disease 2019 patient(2)].","The treatment of critically ill patients with coronavirus disease 2019(COVID-19) faces compelling challenges. In this issue, we'd like to share our first-line treatment experience in treating COVID-19. Hemodynamics need be closely monitored and different types of shock should be distinguished. Vasoconstrictor drugs should be used rationally and alerting of complications is of the same importance. The risk of venous thromboembolism (VTE) needs to be assessed, and effective prevention should be carried out for high-risk patients. It is necessary to consider the possibility of pulmonary thromboembolism (PTE) in patients with sudden onset of oxygenation deterioration, respiratory distress, reduced blood pressure. However, comprehensive analysis of disease state should be taken into the interpretation of abnormally elevated D-Dimer. Nutritional support is the basis of treatment. It's important to establish individual therapy regimens and to evaluate, monitor and adjust dynamically. Under the current epidemic situation, convalescent plasma can only be used empirically, indications need to be strictly screened, the blood transfusion process should be closely monitored and the curative effect should be dynamically evaluated.","Zhonghua Jie He He Hu Xi Za Zhi","Li, X Y","Du, B","Wang, Y S","Kang, H Y J","Wang, F","Sun, B","Qiu, H B","Tong, Z H","32294811"],"abstract":["The treatment of critically ill patients with coronavirus disease 2019(COVID-19) faces compelling challenges. In this issue, we'd like to share our first-line treatment experience in treating COVID-19. Hemodynamics need be closely monitored and different types of shock should be distinguished. Vasoconstrictor drugs should be used rationally and alerting of complications is of the same importance. The risk of venous thromboembolism (VTE) needs to be assessed, and effective prevention should be carried out for high-risk patients. It is necessary to consider the possibility of pulmonary thromboembolism (PTE) in patients with sudden onset of oxygenation deterioration, respiratory distress, reduced blood pressure. However, comprehensive analysis of disease state should be taken into the interpretation of abnormally elevated D-Dimer. Nutritional support is the basis of treatment. It's important to establish individual therapy regimens and to evaluate, monitor and adjust dynamically. Under the current epidemic situation, convalescent plasma can only be used empirically, indications need to be strictly screened, the blood transfusion process should be closely monitored and the curative effect should be dynamically evaluated."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Li, X Y","Du, B","Wang, Y S","Kang, H Y J","Wang, F","Sun, B","Qiu, H B","Tong, Z H"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32294811","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.3760/cma.j.cn112147-20200224-00159","keywords":["convalescent plasma","coronavirus disease 2019, covid-19","nutritional support","vasoconstrictor drugs","venous thromboembolism"],"topics":["Treatment"],"weight":1,"_version_":1666138493224484866,"score":119.23898},{"pmid":32420939,"title":"Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.","text":["Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.","Covid-19 infection is a multisystem disease more frequent in older individuals, especially in those with multiple chronic diseases. This multimorbid and frail population requires attention and a personalized comprehensive assessment in order to avoid the occurrence of adverse outcomes. As other diseases, the COVID-19 presentation in older patients is often atypical with less severe and unspecific symptoms. These subjects both at home and during hospitalization suffer isolation and the lack of support of caregivers. The geriatric care in COVID-19 wards is often missing. The application of additional instruments would be necessary to facilitate and personalize the clinical approach, not only based on diseases but also on functional status. This narrative review starts from diagnostic evaluation, continues with adapted pharmacologic treatment and ends with the recovery phase targeting the nutrition and physical exercise. We developed a check-list of respiratory, gastro-intestinal and other less-specific symptoms, summarized in a table and easily to be filled-up by patients, nurses and general practitioners. As second step, we reported the clinical phases of this disease. Far to be considered just viral infective and respiratory, this disease is also an inflammatory and thrombotic condition with frequent bacterial over-infection. We finally considered timing and selection of treatment, which depend on the disease phase, co-administration of other drugs and require the monitoring of renal, liver and cardiac function. This underlines the role of age not just as a limitation, but also an opportunity to increase the quality and the appropriateness of multidisciplinary and multidimensional intervention in this population.","Acta Biomed","Lauretani, Fulvio","Ravazzoni, Giulia","Roberti, Maria Federica","Longobucco, Yari","Adorni, Elisa","Grossi, Margherita","De Iorio, Aurelio","La Porta, Umberto","Fazio, Chiara","Gallini, Elena","Federici, Raffaele","Salvi, Marco","Ciarrocchi, Erika","Rossi, Francesca","Bergamin, Marina","Bussolati, Giacomo","Grieco, Ilaria","Broccoli, Federica","Zucchini, Irene","Ielo, Giuseppe","Morganti, Simonetta","Artoni, Andrea","Arisi, Arianna","Tagliaferri, Sara","Maggio, Marcello","32420939"],"abstract":["Covid-19 infection is a multisystem disease more frequent in older individuals, especially in those with multiple chronic diseases. This multimorbid and frail population requires attention and a personalized comprehensive assessment in order to avoid the occurrence of adverse outcomes. As other diseases, the COVID-19 presentation in older patients is often atypical with less severe and unspecific symptoms. These subjects both at home and during hospitalization suffer isolation and the lack of support of caregivers. The geriatric care in COVID-19 wards is often missing. The application of additional instruments would be necessary to facilitate and personalize the clinical approach, not only based on diseases but also on functional status. This narrative review starts from diagnostic evaluation, continues with adapted pharmacologic treatment and ends with the recovery phase targeting the nutrition and physical exercise. We developed a check-list of respiratory, gastro-intestinal and other less-specific symptoms, summarized in a table and easily to be filled-up by patients, nurses and general practitioners. As second step, we reported the clinical phases of this disease. Far to be considered just viral infective and respiratory, this disease is also an inflammatory and thrombotic condition with frequent bacterial over-infection. We finally considered timing and selection of treatment, which depend on the disease phase, co-administration of other drugs and require the monitoring of renal, liver and cardiac function. This underlines the role of age not just as a limitation, but also an opportunity to increase the quality and the appropriateness of multidisciplinary and multidimensional intervention in this population."],"journal":"Acta Biomed","authors":["Lauretani, Fulvio","Ravazzoni, Giulia","Roberti, Maria Federica","Longobucco, Yari","Adorni, Elisa","Grossi, Margherita","De Iorio, Aurelio","La Porta, Umberto","Fazio, Chiara","Gallini, Elena","Federici, Raffaele","Salvi, Marco","Ciarrocchi, Erika","Rossi, Francesca","Bergamin, Marina","Bussolati, Giacomo","Grieco, Ilaria","Broccoli, Federica","Zucchini, Irene","Ielo, Giuseppe","Morganti, Simonetta","Artoni, Andrea","Arisi, Arianna","Tagliaferri, Sara","Maggio, Marcello"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420939","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.23750/abm.v91i2.9629","topics":["Treatment"],"weight":1,"_version_":1667159284533690368,"score":116.35499},{"pmid":32286091,"title":"Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?","text":["Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?","In December, 2019, an outbreak of respiratory illness caused by Coronavirus disease 2019 (COVID-19) emerged in Wuhan, China and spread rapidly to other parts of China and around the world. We aimed to identify high-risk groups whose mental health conditions were vulnerable to the COVID-19 outbreak. Data were collected from 7,236 self-selected participants measured by anxiety symptoms, depressive symptoms, and sleep quality. The overall prevalence of anxiety symptoms, depressive symptoms, and poor sleep quality were 35.1%, 20.1%, and 18.2%, respectively. People aged < 35 years reported a higher prevalence of anxiety symptoms and depressive symptoms than people aged >/= 35 years. Healthcare workers have the highest rate of poor sleep compared to other occupations. Healthcare workers/younger people who spent a high level of time (>/= 3 hours/day) had a particular higher prevalence of anxiety symptoms than in those who spent less time (< 1 hours/day and 1-2 hours/day) on the outbreak. During the COVID-19 outbreak, healthcare workers and younger people were at an especially high-risk of displaying psychological impact when they spent too much time thinking about the outbreak. Continuous monitoring of the psychological consequences for high-risk population should become routine as part of targeted interventions during times of crisis.I.","Psychol Health Med","Huang, Yeen","Zhao, Ning","32286091"],"abstract":["In December, 2019, an outbreak of respiratory illness caused by Coronavirus disease 2019 (COVID-19) emerged in Wuhan, China and spread rapidly to other parts of China and around the world. We aimed to identify high-risk groups whose mental health conditions were vulnerable to the COVID-19 outbreak. Data were collected from 7,236 self-selected participants measured by anxiety symptoms, depressive symptoms, and sleep quality. The overall prevalence of anxiety symptoms, depressive symptoms, and poor sleep quality were 35.1%, 20.1%, and 18.2%, respectively. People aged < 35 years reported a higher prevalence of anxiety symptoms and depressive symptoms than people aged >/= 35 years. Healthcare workers have the highest rate of poor sleep compared to other occupations. Healthcare workers/younger people who spent a high level of time (>/= 3 hours/day) had a particular higher prevalence of anxiety symptoms than in those who spent less time (< 1 hours/day and 1-2 hours/day) on the outbreak. During the COVID-19 outbreak, healthcare workers and younger people were at an especially high-risk of displaying psychological impact when they spent too much time thinking about the outbreak. Continuous monitoring of the psychological consequences for high-risk population should become routine as part of targeted interventions during times of crisis.I."],"journal":"Psychol Health Med","authors":["Huang, Yeen","Zhao, Ning"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286091","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1080/13548506.2020.1754438","keywords":["covid-2019","anxiety disorder","depressive symptoms","mental health","sleep quality"],"locations":["Wuhan","China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1666138491345436673,"score":113.63781}]}